Events & Insights
In this exclusive Cell & Gene Therapy Review feature, Darren Head, CEO, and Larry Pitcher, President, share how the combination of Kincell Bio and Cellipont Bioservices came together; and what it means for customers, employees, and the future of the organization.
The conversation explores the complementary science and capabilities behind the merger, plans for continued growth, and an important priority as Kincellis scales: preserving the agility, personalized service, and customer-focused culture of both organizations.
